QT
NTLA icon

Quantbot Technologies’s Intellia Therapeutics NTLA Stock Holding History

Quantbot Technologies’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$512K Buy
+30,260
New +$424K 0.02% 917
2026
Q1 		– Sell
-14,805
Closed -$133K – 2021
2025
Q4 		$133K Buy
+14,805
New +$204K ﹤0.01% 1348
2025
Q2 		– Sell
-6,663
Closed -$47.4K – 1846
2025
Q1 		$47.4K Buy
6,663
+5,959
+846% +$60.2K ﹤0.01% 1328
2024
Q4 		$8.21K Buy
+704
New +$11K ﹤0.01% 1380
2022
Q4 		– Sell
-1,428
Closed -$79K – 1975
2022
Q3 		$79K Sell
1,428
-7,185
-83% -$446K 0.01% 1161
2022
Q2 		$445K Buy
+8,613
New +$437K 0.04% 613
2021
Q4 		– Sell
-3,380
Closed -$453K – 1770
2021
Q3 		$453K Buy
+3,380
New +$512K 0.03% 635
2021
Q1 		– Sell
-454
Closed -$24K – 1655
2020
Q4 		$24K Buy
+454
New +$16.5K ﹤0.01% 986
2020
Q2 		– Sell
-20
Closed – – 1346
2020
Q1 		$0 Sell
20
-3,739
-99% -$50.4K ﹤0.01% 1230
2019
Q4 		$55K Sell
3,759
-1,681
-31% -$23.4K 0.01% 940
2019
Q3 		$72K Buy
5,440
+4,440
+444% +$70.8K 0.01% 904
2019
Q2 		$16K Buy
+1,000
New +$15.7K ﹤0.01% 1061
2018
Q3 		– Sell
-1,506
Closed -$41K – 1457
2018
Q2 		$41K Buy
1,506
+220
+17% +$5.33K ﹤0.01% 1023
2018
Q1 		$27K Buy
1,286
+296
+30% +$7.28K ﹤0.01% 1044
2017
Q4 		$19K Buy
+990
New +$22.9K ﹤0.01% 1075

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Quantbot Technologies's NTLA Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Intellia Therapeutics (NTLA) in Q2 2026: 30,260 shares worth $512K. The stake represents 0.02% of the portfolio and ranks #917 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in NTLA as recently as Q4 2025.

Quantbot Technologies first reported a position in NTLA in Q4 2017 and has held it in 15 quarters since. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Quantbot Technologies held 30,260 shares of Intellia Therapeutics worth $512K as of Q2 2026.
  • Intellia Therapeutics was a new Quantbot Technologies position in Q2 2026.
  • Intellia Therapeutics made up 0.02% of Quantbot Technologies's portfolio in Q2 2026, its #917 holding.
  • Quantbot Technologies first reported a position in Intellia Therapeutics in Q4 2017 and has held it in 15 quarters since.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.